Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

Journal of Hepatology

Volumn 28, Issue 1, 1998, Pages 78-83

  Kaymakoǧlu, Sabahattin ^a   Çakaloǧlu, Yilmaz ^a   Demir, Kadir ^a   Türkoǧlu, Salih ^b   Badur, Selim ^b   Gürel, Selim ^a   Beşişik, Fatih ^a   Çevikbaş, Uǧur ^a   Ökten, Atilla ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul M ^*  (Turkey)

Author keywords

Autoimmune hepatitis; Cryptogenic chronic hepatitis; HLA phenotypes; Immunosuppressive therapy

Indexed keywords

AZATHIOPRINE; LEUKOCYTE ANTIGEN; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; PHENOTYPE; PRIORITY JOURNAL; REMISSION;

EID: 0031886852     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80205-5     Document Type: Article

References (22)

1. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
2. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology. 105:1993;274-278.
3. Jeffers LJ, Hasan F, De Medina M, Reddy R, Parker T, Silva M, et al. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology. 15:1992;187-190.
4. Czaja AJ. Chronic active hepatitis: the challenge for a new nomenclature. Ann Intern Med. 119:1993;510-517.
5. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology. 9:1989;193-197.
6. Czaja AJ, Hay JE, Rakela J. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc. 65:1990;23-30.
7. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology. 104:1993;1755-1761.
8. Scheuer PJ. 4th ed. Liver Biopsy Interpretation. 1988;Bailliere Tindall, London.
9. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 18:1993;998-1005.
10. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel AM. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol. 34:1996;2660-2664.
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
12. Johnson PJ, McFarlane IG. Chronic active hepatitis. Gut. 1991;S63-S72. (Suppl).
13. Maddrey WC. How many types of autoimmune hepatitis are there? Gastroenterology. 105:1993;1571-1575.
14. Manns M, Gerken G, Kyriatsoules A, Staritz M, Meyer zum Büschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. i:1987;292-294.
15. Poralla T, Treichel U, Lohr H, Fleischer B. The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis. 11:1991;215-220.
16. Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Laperche S, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 16:1992;892-898.
17. Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 18:1993;1-9.
18. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer anti-neutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108:1995;1159-1166.
19. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 13:1990;701-706.
20. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 334:1996;897-903.
21. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 110:1996;848-857.
22. Maddrey WC, Combes B. Therapeutic concepts for the management of idiopathic autoimmune chronic hepatitis. Semin Liver Dis. 11:1991;248-255.